LON:CTEC ConvaTec Group (CTEC) Share Price, News & Analysis GBX 194 0.00 (0.00%) As of 06/1/2026 12:14 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesBuy This Stock About ConvaTec Group Stock (LON:CTEC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get ConvaTec Group alerts:Sign Up Key Stats Today's Range 193▼ 201.2050-Day Range 194▼ 240.6052-Week Range 193▼ 311.20Volume1.22 billion shsAverage Volume46.32 million shsMarket Capitalization£3.79 billionP/E Ratio22.56Dividend Yield2.66%Price TargetGBX 308.78Consensus RatingModerate Buy Company Overview ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom. Read More ConvaTec Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks93rd Percentile Overall ScoreCTEC MarketRank™: ConvaTec Group scored higher than 93% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingConvaTec Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.89, and is based on no strong buy ratings, 8 buy ratings, 1 hold rating, and no sell ratings.Upside PotentialConvaTec Group has a consensus price target of GBX 308.78, representing about 59.2% upside from its current price of GBX 194.Amount of Analyst CoverageConvaTec Group has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about ConvaTec Group's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of ConvaTec Group is 22.56, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.27.Price to Earnings Ratio vs. SectorThe P/E ratio of ConvaTec Group is 22.56, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.16.Price to Earnings Growth RatioConvaTec Group has a PEG Ratio of 0.93. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioConvaTec Group has a P/B Ratio of 2.42. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for CTEC. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldConvaTec Group pays a meaningful dividend of 2.66%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthConvaTec Group does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of ConvaTec Group is 78.71%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about ConvaTec Group's dividend. News and Social Media3.7 / 5News Sentiment0.92 News SentimentConvaTec Group has a news sentiment score of 0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for ConvaTec Group this week, compared to 1 article on an average week.Search Interest2 people have searched for CTEC on MarketBeat in the last 30 days. Company Ownership2.2 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, ConvaTec Group insiders have sold 577.90% more of their company's stock than they have bought. Specifically, they have bought £100,500 in company stock and sold £681,288.66 in company stock.Percentage Held by Insiders0.95% of the stock of ConvaTec Group is held by insiders.Percentage Held by Institutions66.28% of the stock of ConvaTec Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about ConvaTec Group's insider trading history. Receive CTEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ConvaTec Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CTEC Stock News HeadlinesConvaTec Group slips Monday, underperforms marketJune 1 at 6:55 PM | marketwatch.comConvaTec Group (LON:CTEC) Insider Jonny Mason Acquires 50,000 SharesMay 28, 2026 | insidertrades.comThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.June 2 at 1:00 AM | Porter & Company (Ad)ConvaTec Group PLC (LON:CTEC) Given Consensus Rating of "Moderate Buy" by BrokeragesMay 26, 2026 | americanbankingnews.comConvaTec Group (LON:CTEC) Price Target Lowered to GBX 294 at JPMorgan Chase & Co.May 23, 2026 | americanbankingnews.comConvatec Launches New Strategy to Hit Upgraded Revenue TargetsApril 9, 2026 | uk.finance.yahoo.comConvaTec Group slides Thursday, underperforms marketMarch 19, 2026 | marketwatch.comConvatec FY25 shares jump 8% on growth target raise despite $72 mln writedownFebruary 24, 2026 | au.investing.comSee More Headlines CTEC Stock Analysis - Frequently Asked Questions How have CTEC shares performed this year? ConvaTec Group's stock was trading at GBX 243.20 at the beginning of 2026. Since then, CTEC stock has decreased by 20.2% and is now trading at GBX 194. How were ConvaTec Group's earnings last quarter? ConvaTec Group PLC (LON:CTEC) announced its quarterly earnings data on Friday, February, 28th. The company reported $12.00 earnings per share for the quarter, missing the consensus estimate of $12.70 by $0.70. ConvaTec Group had a trailing twelve-month return on equity of 10.53% and a net margin of 7.17%. How do I buy shares of ConvaTec Group? Shares of CTEC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of ConvaTec Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that ConvaTec Group investors own include EnQuest (ENQ), Centamin (CEY), Lloyds Banking Group (LLOY), Oxford Biomedica (OXB), Tullow Oil (TLW), Barclays (BARC) and Vodafone Group Public (VOD). Company Calendar Last Earnings2/28/2020Today6/02/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolLON:CTEC CIKN/A Webwww.convatecgroup.com Phone44 11 8952 8100FaxN/AEmployees10,000Year FoundedN/APrice Target and Rating Average Price Target for ConvaTec GroupGBX 308.78 High Price TargetGBX 375 Low Price TargetGBX 230 Potential Upside/Downside+59.2%Consensus RatingModerate Buy Rating Score (0-4)2.89 Research Coverage9 Analysts Profitability EPS (Trailing Twelve Months)GBX 8.60 Trailing P/E Ratio22.56 Forward P/E Ratio14.31 P/E Growth0.93Net Income£188.35 million Net Margins7.17% Pretax MarginN/A Return on Equity10.53% Return on Assets5.01% Debt Debt-to-Equity Ratio106.19 Current Ratio1.53 Quick Ratio0.96 Sales & Book Value Annual Sales£2.44 billion Price / Sales1.55 Cash FlowGBX 11.41 per share Price / Cash Flow17.01 Book ValueGBX 80.01 per share Price / Book2.42Miscellaneous Outstanding Shares1,954,455,000Free FloatN/AMarket Cap£3.79 billion OptionableNot Optionable Beta0.78 The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (LON:CTEC) was last updated on 6/2/2026 by MarketBeat.com Staff. From Our PartnersHow to claim a stake in SpaceX before the June 12 IPOSpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...Brownstone Research | SponsoredThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | SponsoredI paid $5,000 to hear Elon say thisOne investor paid $5,000 to be in a private room with Elon Musk in Los Angeles - and what he heard confirmed a...InvestorPlace | SponsoredPresident Trump just sparked a stock market MELT UPThe real reason Musk, Huang, Cook, and Fink just flew to Beijing Last week, the CEOs of Nvidia, Apple, Spac...Stansberry Research | SponsoredGiving “2022 pre-ChatGPT” vibes (but 10x bigger)When ChatGPT launched in 2022, Nvidia surged 1,800% over three years. Now, Nvidia's CEO suggests July 22nd cou...StocksToTrade | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ConvaTec Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share ConvaTec Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
